Literature DB >> 17639118

Assessing inflammatory status in cardiovascular disease.

Dimitris Tousoulis1, Charalambos Antoniades, Christodoulos Stefanadis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17639118      PMCID: PMC1994393          DOI: 10.1136/hrt.2006.088211

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  27 in total

1.  C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?

Authors:  G D Lowe; J W Yarnell; A Rumley; D Bainton; P M Sweetnam
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-04       Impact factor: 8.311

2.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

3.  Infections, inflammation, and the risk of coronary heart disease.

Authors:  M Roivainen; M Viik-Kajander; T Palosuo; P Toivanen; M Leinonen; P Saikku; L Tenkanen; V Manninen; T Hovi; M Mänttäri
Journal:  Circulation       Date:  2000-01-25       Impact factor: 29.690

4.  Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses.

Authors:  J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; J R Gallimore; M B Pepys
Journal:  BMJ       Date:  2000-07-22

5.  A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.

Authors:  G J Blake; N Dada; J C Fox; J E Manson; P M Ridker
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

6.  Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study.

Authors:  N S Rost; P A Wolf; C S Kase; M Kelly-Hayes; H Silbershatz; J M Massaro; R B D'Agostino; C Franzblau; P W Wilson
Journal:  Stroke       Date:  2001-11       Impact factor: 7.914

7.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

Authors:  Paul M Ridker; Nader Rifai; Lynda Rose; Julie E Buring; Nancy R Cook
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

8.  Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis.

Authors:  I Malik; J Danesh; P Whincup; V Bhatia; O Papacosta; M Walker; L Lennon; A Thomson; D Haskard
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

9.  Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.

Authors:  C J Packard; D S O'Reilly; M J Caslake; A D McMahon; I Ford; J Cooney; C H Macphee; K E Suckling; M Krishna; F E Wilkinson; A Rumley; G D Lowe
Journal:  N Engl J Med       Date:  2000-10-19       Impact factor: 91.245

10.  C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003.

Authors:  S Matthijs Boekholdt; C Erik Hack; Manjinder S Sandhu; Robert Luben; Sheila A Bingham; Nicholas J Wareham; Ron J G Peters; J Wouter Jukema; Nicholas E Day; John J P Kastelein; Kay-Tee Khaw
Journal:  Atherosclerosis       Date:  2005-10-28       Impact factor: 5.162

View more
  16 in total

1.  Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell-platelet-monocyte interaction.

Authors:  Miruna Popa; Sibgha Tahir; Julia Elrod; Su Hwan Kim; Florian Leuschner; Thorsten Kessler; Peter Bugert; Ulrich Pohl; Andreas H Wagner; Markus Hecker
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-23       Impact factor: 11.205

2.  Effects of glutathione S-transferase T1 and M1 deletions on advanced carotid atherosclerosis, oxidative, lipid and inflammatory parameters.

Authors:  Maja Zivković; Aleksandra Stanković; Tamara Djurić; Igor Končar; Ana Kolaković; Vladimir Djurdjević; Lazar Davidović; Dragan Alavantić
Journal:  Mol Biol Rep       Date:  2014-01-10       Impact factor: 2.316

3.  Occupational vehicle-related particulate exposure and inflammatory markers in trucking industry workers.

Authors:  Yueh-Hsiu Mathilda Chiu; Eric Garshick; Jaime E Hart; Donna Spiegelman; Douglas W Dockery; Thomas J Smith; Francine Laden
Journal:  Environ Res       Date:  2016-04-19       Impact factor: 6.498

4.  Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients.

Authors:  Alexandra Mangili; Raabia Ahmad; Robert L Wolfert; Jeffrey Kuvin; Joseph F Polak; Richard H Karas; Christine A Wanke
Journal:  Clin Infect Dis       Date:  2013-12-11       Impact factor: 9.079

Review 5.  Excess Body Weight, Insulin Resistance and Isolated Systolic Hypertension: Potential Pathophysiological Links.

Authors:  Lanfranco D'Elia; Pasquale Strazzullo
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-11-02

Review 6.  Targeting inflammation in metabolic syndrome.

Authors:  Francine K Welty; Abdulhamied Alfaddagh; Tarec K Elajami
Journal:  Transl Res       Date:  2015-07-03       Impact factor: 7.012

7.  Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction.

Authors:  Johanna A Miettinen; Kari Ylitalo; Pirjo Hedberg; Kari Kervinen; Matti Niemelä; Marjaana Säily; Pirjo Koistinen; Eeva-Riitta Savolainen; Heikki Ukkonen; Mikko Pietilä; K E Juhani Airaksinen; Juhani Knuuti; Olli Vuolteenaho; Timo H Mäkikallio; Heikki V Huikuri
Journal:  Clin Res Cardiol       Date:  2010-10-17       Impact factor: 5.460

8.  Association of Rare Loss-Of-Function Alleles in HAL, Serum Histidine: Levels and Incident Coronary Heart Disease.

Authors:  Bing Yu; Alexander H Li; Donna Muzny; Narayanan Veeraraghavan; Paul S de Vries; Joshua C Bis; Solomon K Musani; Danny Alexander; Alanna C Morrison; Oscar H Franco; André Uitterlinden; Albert Hofman; Abbas Dehghan; James G Wilson; Bruce M Psaty; Richard Gibbs; Peng Wei; Eric Boerwinkle
Journal:  Circ Cardiovasc Genet       Date:  2015-01-08

9.  Fatigue in a representative population of older persons and its association with functional impairment, functional limitation, and disability.

Authors:  Sonja Vestergaard; Susan G Nayfield; Kushang V Patel; Basil Eldadah; Matteo Cesari; Luigi Ferrucci; Graziano Ceresini; Jack M Guralnik
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-27       Impact factor: 6.053

Review 10.  Statins as Pleiotropic Modifiers of Vascular Oxidative Stress and Inflammation.

Authors:  Costas Psarros; Evangelos K Economou; Michael Koutsilieris; Charalambos Antoniades
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.